Importantly, multivariate analysis tests controlled for diabetic therapy, diabetic polyneuropathy, serum creatinine, and levels of GGT, showed that Ang-2 remained significantly higher among diabetic subjects with macrovascular disease when compared to those without macrovascular complications. Here, ANGPT2 is linked to diabetic neuropathy.